Vancomycin-resistant enterococcal infections.

By B. Murray. New England Journal of Medicine, 2000

873 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/821ecb90cd228e7e2bdcb36d74191f8eea998a29

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. L. Chiarello
2. J. Siegel
3. C. Walsh
4. M. Jackson
5. D. Levine
6. Y. Belkaid
7. E. Rhinehart
8. T. Hand

In Infectious Diseases

1. L. Chiarello
2. J. Siegel
3. C. Walsh
4. M. Jackson
5. D. Levine
6. J. Bartlett
7. Y. Belkaid
8. E. Rhinehart

In Radiology, Nuclear Medicine and Imaging

1. L. Chiarello
2. J. Siegel
3. C. Walsh
4. M. Jackson
5. D. Levine
6. Y. Belkaid
7. E. Rhinehart
8. T. Hand

Citations in the corpus

• Opinion — anti-infectives: Where will new antibiotics come from? (2003, background): “In fact, life-threatening infections by MRSA and VRE in surgical or cancer patients are often treated with vancomcyi”
• Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (2006, background): “Antibiotic-resistant enterococci have bedeviled infectious diseases clinicians for decades [59].”
• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (2007, background): “This approach is based on the observation that, for some MDROs, detection of colonization may be delayed or missed completely if culture results obtained in the course of routine clinical care are the primary means of identifying colonized patients.(8,38,107,114,151,153,167,168,183,184,187,189,191-1”
• Role of the Microbiota in Immunity and inflammation (2014, background): “…157, March 27, 2014 ª2014 Elsevier Inc. 127 treatment can allow the domination of intestinal microbiota with drug-resistant microbes such as vancomycin-resistant enterococcus (VRE), a pathogen that causes bloodstream infections in immunocompromised patients (Buffie and Pamer, 2013; Murray, 2000).”
• Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut (2016, background): “casseliflavus is an opportunistic pathogen that may cause serious infections in immunosuppressed individuals (27).”
• Vancomycin: a history. (2006, background): “VRE were reported in Europe by 1986 and in the United States by 1987 [51].”
• Homeostatic immunity and the microbiota (2017, neutral): “…the microbiota has also been revealed in clinical and experimental settings in which broad antibiotic treatment allow the domination of intestinal microbiota by drug resistant microbes such as Vancomycin Resistant Enterococcus (VRE) or Clostirudium difficile (Buffie and Pamer, 2013; Murray, 2000).”